http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007133924-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef5ec0d7b0540843675baff86c067060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d06a96cba78a435ebcfe8dc0a4cd119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95dfbe29ba9c540166c3f9ae2f8748f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b60dd42c5c178955f5e436945eaa67d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36f84015e15ef5194222a4ec06303eab
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G63-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D167-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G63-664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L67-04
filingDate 2007-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15de21e31171da22e2c80d18837341ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2532c0673695c2f01abbaac1a6efed4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5702feeed9b0cea079a236e6a8ff0379
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41fce4167b8768609e830a70f511fb36
publicationDate 2008-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007133924-A3
titleOfInvention Biodegradable modified caprolactone polymers for fabricating and coating medical devices
abstract Disclosed herein are biodegradable modified caprolactone polymers for coating and forming medical devices. The properties of the polymers are fine tuned for optimal performance depending on the medical purpose. Moreover, the polymers are suitable for the controlled in situ release of drugs at the treatment site.
priorityDate 2006-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4379138-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6346599-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401586

Total number of triples: 33.